The licensing and integration of Scitara DLX technology will offer IDBS users plug-and-play connectivity to any instrument or application in regulated and non-regulated laboratories
Guildford, UK & Marlborough, MA, USA — IDBS, a leading innovator in Biopharmaceutical Lifecycle Management (BPLM), and Scitara, a pioneer in laboratory IoT, have entered into a strategic partnership to create a combined solution that will significantly extend IDBS Polar BPLM’s laboratory data connectivity and instrument integration capabilities. This integrated solution augments the Polar workflow capabilities by addressing the challenge of sharing and digitalizing laboratory data across the biopharmaceutical lifecycle, while ensuring data integrity and supporting insight.
Out-of-the-box Polar workflows powered by Scitara DLX will remove risky and inefficient manual processes and deliver high quality contextualised data that supports decision making and insights throughout the biopharmaceutical lifecycle. The combined solution will provide out-of-the-box integration with instruments, equipment, informatics systems and enterprise platforms, significantly reducing the time and complexity of Polar implementations.
“Universal access to laboratory data is crucial to the success of science-based industry’s digital transformation journey,” noted Ajit Nagral, CEO of Scitara. “The Scitara Digital Laboratory Exchange, DLX platform provides seamless peer-to-peer data connectivity for all laboratory instruments and applications, enables simple yet comprehensive data transformation and workflow automation, and creates a trusted digital trail of all lab data transactions for further analysis and decision-making. Our partnership with IDBS will enable their BPLM solution to interoperate with hundreds of systems connected to our laboratory data exchange backbone. We are excited to bring these capabilities to the IDBS user community and look forward to regulated and non-regulated customers reaping the benefits of our joint solution.
“Seamless integration of workflows, equipment and data across the biopharmaceutical lifecycle is one of the fundamental challenges in reducing the time and cost of developing novel biological therapies and vaccines,” said Pietro Forgione, Vice President, Strategy at IDBS.
“Scitara DLX will power the IDBS Polar platform by delivering best-in-class integration capabilities that uphold the highest standards of data integrity and remove roadblocks in capturing, contextualising and gaining insights from data. By integrating with the IDBS cloud, Scitara DLX will also extend these capabilities to the broader IDBS cloud customer base.”
“We are delighted to be working with Scitara to provide out-of-the-box solutions that help our customers more quickly realise the benefits of Polar BPLM, gaining the insights they need to accelerate therapy and vaccine development programmes.”
Scitara is a global provider of laboratory-specific, cloud-based software solutions for the life sciences and other science-based industries. Our solutions are powering the digital transformation of scientific laboratories by enabling them with modern lab data connectivity infrastructure and tools to accelerate science. Scitara DLX allows plug-and-play connectivity between any device, instrument, application, informatics system, web service or lab resource, using our connector technology, automation of workflows, task notifications, and bi-directional data exchange through our powerful and easy-to-use orchestration engine, compliant transformation of data in-flight using our transformation tools and libraries, and capture, monitoring, and analysis of all data transactions using our monitoring capabilities.
IDBS helps research and development (R&D) teams around the world make discoveries that have the potential to transform the lives of populations worldwide.
IDBS Polar is the world’s first BioPharma Lifecycle Management (BPLM) system, a cloud-based platform designed to accelerate biopharmaceutical development by tackling the biggest challenges in process design, optimization, scale-up and technology transfer.
Our diverse customer list includes 22 of the top 25 global pharmaceutical companies, and other R&D-driven organizations in biotechnology, agricultural sciences, chemicals, consumer goods, energy, food and beverage, and healthcare serving over 50,000 researchers in 25 countries.
Privately held since 1989, IDBS joined Danaher’s Life Sciences platform at the end of 2017. IDBS will help provide the foundation for a portfolio of life sciences informatics and knowledge management solutions, within Danaher, that will accelerate the speed of discovering, developing and producing new drugs and therapies.